Request for Information (RFI) for NCI's FFRDC: Draft Section M Small Business Participation Language

Notice Type: Special Notice Notice Number: HHS-NIH-NCI-RFI-MOSB-75N91020R00062-22 Synopsis: Request for Information (RFI) for the National Cancer Institute's Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR) BACKGROUND: The National Cancer Institute (NCI) is requesting information from all parties who may be interested in the re-competition of the NCI's FFRDC. The FFRDC provides rapid response capabilities and one-of-a-kind resources for the biomedical research community within NCI, NIH and other Federal Agencies. Located in Frederick, MD, the NCI's FFRDC is a Government-Owned Contractor-Operated (GOCO) research facility with a unique array of research support and advanced technologies, whose purpose is to bridge the gaps from discovery to healthcare delivery; to accelerate the development of new technologies and prototype treatments for patients; and to pave the way for new advances to enter clinical trials for testing, approval, and delivery to patients via the commercial sector. Entities authorized to operate, manage, or administer an FFRDC include: a university, a consortium of universities, other not-for-profit or nonprofit organizations, industrial firms as autonomous organizations (identified separately from any parent organization), or industry/academia partnerships. For more information, please refer to the website at http://frederick.cancer.gov/. DISCLAIMER TO PROSPECTIVE RESPONDENTS: THIS IS A REQUEST FOR INFORMATION (RFI). This is NOT a solicitation for proposals, capability statements, proposal abstracts, or quotations. The purpose of this RFI is to obtain knowledge and information for project planning purposes. Interested parties are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this RFI; all costs associated with responding to this RFI will be solely at the interested party's expense. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Those not responding to this RFI are not prohibited from participation in any future RFP, if any. If a solicitation is released, it will be synopsized on Sam.gov (SAM) in addition to the NCI Office of Acquisition's website under the FNLCR Acquisition Portal at https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/acquisition-noticesInformation posted to Beta SAM takes precedence over information provided elsewhere and serves as the Government's official government-wide point of entry (GPE). INFORMATION FROM INDUSTRY: Interested organizations are asked to provide input that addresses all of the following questions related to the attached Draft Section M Small Business Participation Language. Does the solicitation provide sufficient information for offerors to develop a robust small business outreach/participation plan that could be demonstrated in a proposal and evaluated as outlined in sections M.3.1. through M.3.7? ?If not, what information would be necessary? Can the offeror provide documentation of positive past performance in meeting small business subcontracting goals in an R&D environment? Can the offeror demonstrate past examples of meeting/exceeding small business goals? Does your organization have any existing partnerships with small businesses in an R&D and/or FFRDC environment that would allow you to propose a robust small business outreach? Can your organization document any experience in developing and maintaining a robust small business outreach program for an R&D contract? 2. DESCRIPTION OF INFORMATION REQUESTED: Interested parties should provide their respective answers below each stated question. You must submit your response electronically in a MS Word or Adobe Portable Document Format (PDF) in no more than ten (10) single-spaced, single-sided pages, with standard 1 margins, and 12-point Times New Roman font. Any pages exceeding the page limitation designated herein will not be reviewed. The due date for the submission of responses to this RFI is 4:00 PM EDT on February 14, 2022. The RFI response must be sent via e-mail to contact@example.gov with subject line - Response to RFI Notice Number: HHS-NIH-NCI-RFI-MOSB-75N91020R00062-22. Any questions related to this RFI should be directed to contact@example.gov with the subject line entitled: - Question to RFI Notice Number: HHS-NIH-NCI-RFI-MOSB-75N91020R00062-22. ATTACHMENTS Attachment 1- Draft Section M Small Business Participation Language CONFIDENTIALITY: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use information provided by respondents for any purpose(s) it deems necessary and legally appropriate.